Bausch Health Companies Inc. (BHC) Stock

Bausch Health Companies Inc. (BHC) is a Healthcare stock trading at $4.76 (as of 2026-06-18), with a market capitalization of $1.85B and a trailing P/E of -1.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Bausch Health Companies Inc. and its subsidiaries develop, manufacture, and market pharmaceutical, medical device, and over-the-counter products. Its businesses include segments such as Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products, serving customers in areas including eye health, gastroenterology, and dermatology.

Valuation — source: SEC EDGAR (first-party)
Price	$4.76
Market Cap	$1.85B
P/E Ratio	-1.6
EV / EBITDA	12.0
Price / Book	-1.75
Price / Sales	0.18
DCF Value (model)	$-15.01
DCF Upside vs Price	-415.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$10.27B
Net Margin	1.5%
Return on Equity	111.6%
Debt / Equity	-19.19
Current Ratio	1.32
Revenue Growth (YoY)	11.7%
EPS Growth (YoY)	2287.5%
FCF Growth (YoY)	26.0%

Financial Health — source: SEC EDGAR
Altman Z-Score	0.23 (distress)

Valuation vs Sector & Industry
Stock P/E	-1.6
Sector P/E (Healthcare)	21.0
Industry P/E (Pharmaceutical Products)	17.3
vs Sector	-107.5%
vs Industry	-109.0%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Buys (12mo)	5
Insider Sells (12mo)	2
Top Institutional Holder	PAULSON & CO. INC. ($395.58M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Thomas J. Appio
Employees	20,700
Country	CA
IPO Date	1994-03-29

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.